Thank you Harveshp Mogal for coming back to Wake Forest to present at Grand Rounds! Perry Shen Wake Forest Surgical Oncology

Can we boost #HIPEC effectiveness with Bromelain? Exciting new research from #WFORCE group, reveals its dual action as a mucolytic and cytotoxic agent, against appendiceal cancer organoids.#cancerresearch #innovation Dive in the study here: rdcu.be/dGZE2

Congratulations and Welcome to the Wake Forest Family! MedStar Georgetown Perry Shen Wake Forest Surgical Oncology Society of Surgical Oncology

SSO supports cancer research and promotes opportunities for development and success of surgeon scientists. SSO has a new webpage for research opportunities from SSO members for surgical oncologists, including research fellowships. Check it out! 👉surgonc.org/resources/rese…

Lumps and Bumps for the General Surgeon - Perry Shen Wake Forest Surgical Oncology

Dr. Shen presenting our data on gastrectomy during CRS/HIPEC at the Southern Surgical today Perry Shen Wake Forest Surgical Oncology

Honored to discuss and close our manuscript presentation at the Southern Surgical Association meeting today Wake Forest Surgical Oncology #SSA2024

Long term outcomes of the clinical trial comparing CRS/HIPEC with oxaliplatin vs MMC in patients with appendiceal mucinous neoplasms

Perry Shen presenting updates on appendiceal cancer using Wake Forest Surgical Oncology data #GI25

Our poster at #ACT2025 on outcomes of CRS+HIPEC for 900 patients with appendiceal neoplasms. Wake Forest Surgical Oncology

Fun times at #SSO2025 ! It is always a pleasure to reunite with former residents and fellows as well as current and incoming fellows! @FabianJohnston Perry Shen Wake Forest Surgical Oncology